Affymetrix, Inc.
Genomics company reports net income of $0.25 per share
Published in Lab Business Week, November 21st, 2004
The company reported net income of approximately $15.4 million or $0.25 per basic and diluted share in the third quarter of 2004, as compared to a net income of $5.8 million or $0.10 per basic and diluted share in the third quarter of 2003.
Total revenue for the quarter was $79.9 million, of which $0.9 million was related to the sale of products and wafers to Perlegen Sciences, Inc., as compared to total revenue of $76.2 million in the third quarter of 2003, of which $2.7 million was related to the sale of products and wafers to Perlegen.
Third quarter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-11-21)
More Articles from Lab Business Week
- AVVAA World Health Care Products
Biotech company reports loss of $0.03 per share - Abaxis, Inc.
Blood test maker reports record sales for 2Q - Abbott Laboratories
Pharmaceutical firm reports 10.2% sales increase in third quarter - Advanced Medical Optics, Inc.
Ophthalmic surgical device maker reports 31.2% increase in revenue - Alpharma, Inc.
Pharmaceutical firm revises third quarter 2004 guidance - Amgen, Inc.
Biotech firm reports per share earnings increased 21% - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
